Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Q Eichacker

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Intensive Care Medicine|October 8, 2008
Once is not enough: clinical trials in sepsisDaniel A Sweeney, Robert L Danner, Peter Q Eichacker, et al.
Critical Care Medicine|July 25, 2020
Inhibitory Immune Checkpoint Molecule Expression in Clinical Sepsis Studies: A Systematic ReviewLindsay M Busch, Junfeng Sun, Peter Q Eichacker, et al.
Current Opinion in Critical Care|December 24, 2004
Defining the standard of care in randomized controlled trials of titrated therapiesKatherine J Deans, Peter C Minneci, Peter Q Eichacker, et al.
Expert Opinion on Investigational Drugs|April 30, 2015
An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsisLernik Ohanjanian, Kenneth E Remy, Yan Li, et al.
The New England Journal of Medicine|September 27, 2002
Risks and benefits of activated protein C treatment for severe sepsisH Shaw Warren, Anthony F Suffredini, Peter Q Eichacker, et al.
BMC Medicine|October 11, 2013
B. anthracis associated cardiovascular dysfunction and shock: the potential contribution of both non-toxin and toxin componentsKenneth E Remy, Ping Qiu, Yan Li, et al.
Toxins|December 7, 2017
The Potential Pathogenic Contributions of Endothelial Barrier and Arterial Contractile Dysfunction to Shock Due to B. anthracis Lethal and Edema ToxinsDante A Suffredini, Xizhong Cui, Wanying Xu, et al.
American Journal of Respiratory and Critical Care Medicine|August 20, 2011
Anthrax infectionDaniel A Sweeney, Caitlin W Hicks, Xizhong Cui, et al.
The Journal of Trauma|April 13, 2005
Novel therapies for sepsis: a reviewKatherine J Deans, Michael Haley, Charles Natanson, et al.
Intensive Care Medicine|April 25, 2012
An overview of anthrax infection including the recently identified form of disease in injection drug usersCaitlin W Hicks, Daniel A Sweeney, Xizhong Cui, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Intensive Care Medicine|October 8, 2008
Once is not enough: clinical trials in sepsisDaniel A Sweeney, Robert L Danner, Peter Q Eichacker, et al.
Critical Care Medicine|July 25, 2020
Inhibitory Immune Checkpoint Molecule Expression in Clinical Sepsis Studies: A Systematic ReviewLindsay M Busch, Junfeng Sun, Peter Q Eichacker, et al.
Current Opinion in Critical Care|December 24, 2004
Defining the standard of care in randomized controlled trials of titrated therapiesKatherine J Deans, Peter C Minneci, Peter Q Eichacker, et al.
Expert Opinion on Investigational Drugs|April 30, 2015
An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsisLernik Ohanjanian, Kenneth E Remy, Yan Li, et al.
The New England Journal of Medicine|September 27, 2002
Risks and benefits of activated protein C treatment for severe sepsisH Shaw Warren, Anthony F Suffredini, Peter Q Eichacker, et al.
BMC Medicine|October 11, 2013
B. anthracis associated cardiovascular dysfunction and shock: the potential contribution of both non-toxin and toxin componentsKenneth E Remy, Ping Qiu, Yan Li, et al.
Toxins|December 7, 2017
The Potential Pathogenic Contributions of Endothelial Barrier and Arterial Contractile Dysfunction to Shock Due to B. anthracis Lethal and Edema ToxinsDante A Suffredini, Xizhong Cui, Wanying Xu, et al.
American Journal of Respiratory and Critical Care Medicine|August 20, 2011
Anthrax infectionDaniel A Sweeney, Caitlin W Hicks, Xizhong Cui, et al.
The Journal of Trauma|April 13, 2005
Novel therapies for sepsis: a reviewKatherine J Deans, Michael Haley, Charles Natanson, et al.
Intensive Care Medicine|April 25, 2012
An overview of anthrax infection including the recently identified form of disease in injection drug usersCaitlin W Hicks, Daniel A Sweeney, Xizhong Cui, et al.
Pageof 13